A study of JSKN033 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called JSKN033 for people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. The goal is to see if JSKN033 is safe and effective for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have an advanced solid tumor that cannot be removed by surgery or has spread, and standard treatments no longer work or cause too many side effects.
- You are generally well enough to be up and about (able to do light housework or office work).
- Your tumor can be measured on a scan.
- You have not had certain other cancer treatments or vaccines in the past few weeks.
- Your major organs (like liver, kidneys, bone marrow) are working well enough.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SSGJ-709 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug, JSKN022, for people with advanced solid tumors that have stopped responding to standard treatments or are not eligible for them. The goal is to see if the drug is safe and effective.
This trial tests a new drug, JSKN021, for people with advanced solid tumors that have not responded to standard treatments, are not tolerated to them, or have no standard options. The goal is to see if the drug is safe and effective in treating these cancers.
This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
This trial tests a new medicine called JSKN016HC for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it works in the body.
This trial tests a new drug called JSKN016 for people with advanced cancer that has not responded to other treatments. It focuses on certain lung and breast cancers with specific genetic markers.
Hear when a new Advanced Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.